Senolytic Drugs Show Promise and Peril for Heart Disease Treatment
New review reveals senolytic therapies can both help and harm cardiovascular health, challenging clinical translation.
4989 articles
New review reveals senolytic therapies can both help and harm cardiovascular health, challenging clinical translation.
Comprehensive review reveals how cellular senescence drives lung aging and disease, highlighting therapeutic potential of senolytics and senomorphics.
Researchers discover a high-plasticity cell state that enables cancer progression and therapy resistance, offering new therapeutic targets.
Researchers identify specific inflammatory kidney cells that could be targeted with existing drugs to slow chronic kidney disease progression.
New review reveals how aging skin cells trigger chronic inflammation and tissue breakdown, pointing to promising anti-aging therapies.
New research reveals how elevated IGF-1 accelerates hair follicle aging through stem cell senescence, with promising interventions to restore hair health.
New targeted approaches promise safer senescent cell clearance for aging populations by distinguishing between helpful and harmful cellular states.
Study shows senolytic combination therapy reduces cellular aging in gums and prevents periodontal bone loss in aging mice.
New research reveals how senescent cells promote kidney damage by converting immune cells into scar tissue producers.
Scientists discover CD4-Eomes T cells naturally eliminate aging cells, offering new targets for longevity interventions.
Researchers develop targeted siRNA therapy that reverses cellular aging in cartilage, offering new hope for osteoarthritis treatment.
Novel therapy uses targeted nanoparticles to eliminate inflammatory brain cells that worsen stroke damage and hinder recovery.